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Summary 
Commitment of mammalian cells to enter S phase en- 
ables the transcription factor E2F-1 to activate certain 
genes whose products mediate cell cycle advance. In 
S phase, E2F-1 forms stable complexes with cyclin 
A-kinase, which in turn eliminates E2F-1 DNA binding 
function. Here, we show that suppression of E2F-1 
DNA-binding activity by cyclin A-kinase is linked to 
orderly S phase progression. Disruption of this linkage 
resulted in S phase delay/arrest followed by regrowth 
orapoptosis, depending upon whetherthe DNA-bound 
E2F-1 could transactivate. Hence, the unscheduled 
presence of E2F-1 on specific DNA sequences during 
S phase can activate a specific S phase checkpoint, 
thereby linking transcription, DNA replication, and cell 
cycle control. 
Introduction 
Temporal control of the transcription of geneswhose prod- 
ucts contribute to cell cycle progression is critical for accu- 
rate transmission of genetic information and controlled cell 
replication. Central to the temporal control mechanism is a 
relationship between the behavior of certain transcription 
factors that contribute to cell cycle-dependent gene con- 
trol,e.g., theE2Ffamily(Nevins, 1992; LaThangue, 1994) 
and the activities of proteins that orchestrate individual 
cell cycle events, the cyclin-cdk complexes (Hunter and 
Pines, 1994). 
The molecular mechanisms by which cyclin-cdk com- 
plexes modulate the activity of E2F is best understood in 
the case of E2F-1, a transcription factor involved in the 
timely activation of genes whose products contribute to Gl 
exit and S phase traverse. According to a current model, 
during mid- to late-Gl, E2F-1 (Helin et al., 1992; Kaelin 
et al., 1992; Shan et al., 1992) bound to its heterodimeric 
DP partner (Girling et al., 1993) complexes with the 
un(der)phosphorylated species of pRB. Cyclin D-cdkC or 
cyclin D-cdk6-dependent phosphorylation of pRB in mid- 
to late-G1 (for reviews see Sherr, 1993; Weinberg, 1995) 
results in the dissociation of E2F-1 (bound to DP). E2F-1 
is, in turn, freed of pocket protein regulation, and certain 
E2F-l-responsive promoters, including at least some that 
govern the synthesis of products that stimulate cell cycle 
progression, are activated. 
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As cells complete Gl and move into S, E2F-1 forms 
stable complexes with cyclin A-kinase. The bound en- 
zyme, in turn, phosphorylates EPF-l-bound DP-1. This re- 
action leads to suppression of E2F-1 DNA-binding activity 
(Krek et al., 1994). A possible consequence of this effect is 
diminished activation of the above-noted, E2F-stimulated 
promoters. Indeed, certain E2F-dependent promoters 
(Means et al., 1992; Lam and Watson, 1993) are both acti- 
vated in late-G1 and subsequently inactivated in S in an 
E2F site-dependent manner. These conclusions are sup- 
ported by the findings of Dynlacht et al. (1994) who de- 
veloped an in vitro transcription assay that recapitulates 
E2F-specific transactivation through a cognate E2F DNA- 
binding site. Addition of purified cyclin A-cdk2 to this E2F- 
responsive assay led to phosphorylation of E2F-I-DP-1 
heterodimers and loss of E2F-l-dependent DNA binding 
and transactivation function. Cyclin E-cdk2, by contrast, 
was inactive in this system. 
That cyclin A-kinase alone was active here is compati- 
ble with the fact that the E2F-1 cyclin-binding sequence 
failed to bind cyclin E-kinase or any other cyclin (Krek et 
al., 1994). Of note, cyclin A-kinase function is essential 
for S phase progression (Girard et al., 1991; Pagan0 et 
al., 1992; Zindy et al., 1992). 
Thus, it appears that E2F-1 function is tightly controlled 
in Gl and S. The time-controlled activation of E2F-1 in 
mid- to late-G1 as well as its time-controlled inactivation in 
S is triggered by distinct classes of cyclin-cdk complexes 
and, thus, provides one paradigm for how waves of gene 
expression are generated in mammalian cells at specific 
cell cycle intervals. 
No information exists regarding the biological conse- 
quencesof adysfunctional cyclin A-kinase-E2F-1 interac- 
tion during S phase. In this report, we describe results 
that provide evidence that timely regulation of E2F-1 DNA 
binding function by a cyclin A-kinase is essential for or- 
derly S phase progression, cell survival, and suppression 
of fibroblast transformation. Thus, one aspect of the 
largely unknown S phase regulatory function(s) of cyclin 
A-kinase may be mediated through its ability to modulate 
the behavior of E2F-1. 
Results 
E2F-1 Mutants Defective in Cyclin A-Kinase Binding 
Cause Apoptosis of Fibroblasts in High Serum 
To probe the biological effect(s) of cyclin A-kinase-E2F-1 
complex formation, recombinant retroviruses (Figure 1A) 
were used to introduce hemagglutinin (HA)-tagged ver- 
sions of E2F-l(wt) and mutant derivatives of it that are 
defective in cyclin A-kinase binding, i.e., E2F-l(A24) and 
E2F-l(A7) (Krek et al., 1994) into NIH 3T3 fibroblasts. 
The goal of introducing these mutants was to bypass the 
kinase function of cyclin A-kinase-E2F-1 -DP complexes. 
This viral production system (see Experimental Proce- 
dures) led to high titer retrovirus stocks enabling quantita- 
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Figure 1. Synthesis of Various E2F-1 Species in Retrovirus-Infected 
NIH 3T3 Cells 
(A) Schematic depiction of the retroviral expression plasmid pBabe 
(puro) (top) and of E2F-1 (wt) and two cyclin A-kinase binding-defective 
mutant derivatives of it, E2F-l(A24) and E2F-l(A7) (bottom). HA- 
tagged versions of these cDNAs were cloned into pBabe(puro). The 
schematic diagram depicts the N-terminal cyclin A-kinase binding do- 
main (cyc A-cdk), the DNA-binding domain (DBD), and the transactiva- 
tion domain (TAD) of E2F-1. 
(B) NIH 3T3 cells were infected with identical volumes (3.5 ml) of tissue 
culture supernatant containing retroviruses encoding the various 
E2F-1 species noted in (A). After infection (24 hr), lysates were pre- 
pared from cells infected with vector virus (lane I), or with retroviruses 
bearing cDNAs encoding HA-EPF-l(wt) (lane 2) HA-E2F-l(A24) (lane 
3) or HA-E2F-l(A7) (lane 4) equalized for protein content, and then 
processed for Western blotting with an anti-HA MAb, 12CA5. The 
bracket marks the positions of various HA-E2F-1 species. From the 
data in the Figure, equivalent quantities of tissue culture supernatant 
contain equivalent amounts of E2F-1 protein inducing virus. 
tive infection of a large cell population. In addition, al- 
though each recombinant retrovirus encoded a puromycin 
resistance allele, no drug selection was applied in this first 
set of E2F-1 infection experiments. 
To detect the production of the relevant HA-tagged 
E2F-1 products, extracts were prepared from each of the 
infected cultures 24 hr postinfection (hpi), and equivalent 
amounts of cell protein from each were subjected to West- 
ern blotting with an anti-HA antibody. As shown in Figure 
1 B, similar levels of each of the expected E2F-1 species 
were present (lanes 2-4). None were detected in vector- 
infected cell extracts (Figure 1 B, lane 1). Thus, any differ- 
ences in the behavior of wild-type or mutant E2F-1 -infected 
cell populations cannot be ascribed to differences in the 
quantity of E2F-1 proteins present. 
Microscopic examination of cells infected with the afore- 
mentioned retroviruses revealed no significant morpho- 
logical changes at 24 hpi (Figure 2A, left). At 48 hpi, 
however, virtually all cells of E2F-l(A24)- or E2F-l(A7)- 
infected cultures revealed clearly altered cell morphology 
(compare Figures 2Af and 2Ah with 2Ab and 2Ad). A large 
fraction of the E2F-l(A24)- and EPF-l(A7)infected cells 
were small. Others had rounded up and detached from 
the culture plate, suggesting cell death. No such changes 
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Figure 2. Short-Term Synthesis of HA-EPF-l(A.24) or HA-E2F-l(A7) Leads to Morphological Alterations and Apoptosis of NIH 3T3 Cells 
(A) NIH 3T3 cells were infected with recombinant retroviruses as described in Figure 1B. They were examined by light microscopy at 24 hpi (left) 
and 48 hpi (right). Representative phase-contrast micrographs of cells infected with vector (a and b), HA-EPF-l(wt) (c and d), HA-E2F-i(A24) 
(e and f), and HA-E2F-l(A7) (g and h) are shown. 
(B) Visualization of nuclear morphology of recombinant retrovirus-infected cells described in (A) at 48 hpi by fluorescence after staining with DAPI. 
(a)-(d) show vector-, HA-E2F-l(wt)-, HA-E2F-1(24)-. and HA-EZF-l(A7)-Infected cells, respectively. 
(C) Low molecular weight DNA of NIH 3T3 cells infected by the retroviruses described in (A) was isolated at 48 hpi and analyzed for fragmentation. 
DNA was resolved by electrophoresis in a 1% agarose gel and visualized by ethidium bromide staining. Lanes l-4 show DNA from cells infected 
by vector, HA-EPF-l(wt), HA-E2F-1(24), and HA-E2F-l(A7) viruses, respectively. 
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were observed in either vector-infected or wild-type E2F-l- 
infected cells (Figures 2Ab and 2Ad, respectively). These 
data suggest that time-dependent cyclin A-kinase-EPF-1 
binding is critical for the maintenance of normal cell mor- 
phology and cell survival. In addition, that practically all 
cells of an E2F-l(A24)-or E2F-l(A7)-infected culture were 
morphologically altered suggests that the efficiency of in- 
fection was high. 
Next, we asked whether E2F-l(A24)- or E2F-l(A7)- 
induced death of NIH 3T3 was due to apoptosis. Key fea- 
tures of this process are chromatin condensation and in- 
ternucleosomal DNA fragmentation. As visualized by 
staining with 2,4-diamidino-2-phenylindole (DAPI), signifi- 
cant numbers of E2F-l(A24)- or E2F-l(A7)-infected cul- 
tures contained condensed chromatin (Figures 2Bc and 
2Bd). In contrast, vector-infected or wild-type E2F-l- 
infected populations contained few cells with altered chro- 
matin structure (Figures2Ba and 2Bb). Moreover, the DNA 
of E2F-1 (A24)- or E2F-1 (A7)-producing cells produced a 
characteristic “ladder” in agarose gels (Figure 2C, lanes 
3 and 4). Neither vector-infected nor wild-type E2F-l- 
infected cells contained degraded DNA(Figure 2C, lanes 1 
and 2). These observations indicate that uncoupling E2F-1 
from its natural S phase regulator, cyclin A-kinase, results 
in the activation of an intrinsic cell suicide (apoptosis) pro- 
gram. Since E2F-l(A24)- or E2F-l(A7)-mediated apoptosis 
occurred in the presence of high serum, one could argue 
that death, in this case, was not due to growth or survival 
factor deficiency (or both), but rather to perturbations of 
cell cycle progression. 
S Phase Delay/Arrest Precedes E2F-1 (A24)- or 
E2F-l(A7)-Induced Apoptosis 
To investigate whether E2F-l(A24)- or E2F-l(A7)-induced 
apoptosis was a consequence of a perturbation in the cell 
cycle, we analyzed the DNA content of each of the infected 
cell populations by fluorescence-activated cell sorting 
(FACS) at various times after infection. At 24 hpi, most 
cells of vector-infected cultures were in Gl and S (44% 
and 38%, respectively); 18% of the culture had a G2/M 
DNA content (Figure 3A, left, bars marked vet). This cell 
cycle profile resembled closely that of exponentially grow- 
ing uninfected NIH 3T3 cells (data not shown). Wild-type 
E2F-l-infected cells displayed a similar cell cycle profile 
(Figure 3A, left, bars marked wt). By contrast, most cells 
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from E2F-1 (A24)- or E2F-1 (A7)-infected cultures were in 
S phase (54% and 52%, respectively) (Figure 3A, left, bars 
marked A24 and A7). 
At 48 hpi, the profiles of the vector-infected or wild-type 
E2F-l-infected cultures were similar to those at 24 hpi 
(Figure 3A, right, bars marked vet and wt). Most E2F- 
l(A24)- or E2F-l(A7)-infected cells remained in S (Figure 
3A, right, bars marked A24 and A7). However, in contrast 
with the 24 hr timepoint, these cultures contained fewer 
G2/M cells and an increased number of Gl cells (Figure 
3A, right, bars marked A24 and A7). These results suggest 
that normal progression through S phase can be linked to 
the existence of stable cyclin A-kinase-E2F-1 complexes. 
Consistent with the above (see Figure 2), we observed 
at 48 hpi a new subpopulation of cells in E2F-l(A24)- or 
E2F-1 (A7)-infected cultures that was characterized by less 
than a 2n DNA content. Owing to chromatin condensation 
and DNA cleavage, apoptotic cells show less propidium 
iodide fluorescence than viable cells and, thus, appear as 
a subdiploid population (Nicoletti et al., 1991). Approxi- 
mately 20% of cells from E2F-l(A24)- or E2F-l(A7)- 
infected cultures were apoptotic by this criterion (Figure 
38, bars marked A24 and A7). Analogous cells were ab- 
sent from the vector-infected or wild-type E2F-l-infected 
cultures (Figure 3B, bars marked vet and wt). 
Induction of S Phase Delay/Arrest by a DP-1 Mutant 
That Cannot Be Phosphorylated by EPF-l-Bound 
Cyclin A-Kinase 
Earlier results pointed to DP-1 as a key physiological sub- 
strateofcyclin A-kinase boundtoE2F-1 (Kreketal., 1994). 
Moreover, a strict correlation between E2F-1 -bound cyclin 
A-kinase phosphorylation of DP-1 on serine and loss of 
E2F-1 DNA-binding activity was demonstrated. Given the 
linkage between a defect in cyclin A-kinase binding to 
E2F-1 and S phase arrest/delay, we analyzed the behavior 
of cells producing a DP-1 mutant that cannot be phosphor- 
ylated by cyclin A-kinase. The coding region of mouse 
DP-1 (Girling et al., 1993) contains a cluster of cdk phos- 
phorylation sites (SP and TP motifs) near the N-terminus. 
Therefore, a mutant of DP-1 lacking these potential phos- 
phoacceptor sites was constructed and equipped with an 
N-terminal T7 tag. This species, T7-DP-1 (AP), bears ser- 
ine to alanine substitutions at positions 23,80, and 98 and 
threonine to alanine substitutions at positions 66 and 83. 
Figure 3. Synthesis of E2F-l(A24) or E2F- 
l(A7) Induces S Phase Delay/Arrest 
48 how p I (A) NIH 3T3 cells were infected with vector, 
I HA-E2F-l(W), HA-E2F-l(A24), or HA-E2F- 
l(A7) virus and examined for DNA content by 
.1 
proprdrum iodide staining and flow cytometry 
at 24 hpi (left) and 48 hpr (right) Bars represent 
percentageof cells in Gl, S, and G2/M. Cellular 
debris and apoptotic cells were gated out to 
allow optrmal quantitation of Gl, S, and G2/M 
populations. One representatrve experiment 
out of three is shown. 
(B) Fractions of cultures displaymg a DNA con- 
tent less than that of Gl cells in the analysrs 
of (A) are plotted as percent apoptotrc cells 
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No other SP motifs exist in the DP-1 sequence. The sole 
remaining TP site (at position 388) was not modified, since 
phosphorylation of DP-1 in vivo by the E2F-l-bound cyclin 
A-kinase likely occurs predominantly, if not exclusively, 
on serine. 
The resulting mutant protein appeared to be as stable as 
wild-type DP-1, as measured in [35S]methionine-labeling 
experiments (data not shown), and like wild-type DP-1, it 
formed stable heterodimers with wild-type E2F-1 as shown 
in gel shift assays (Figure 4A, compare lanes 4-6 with 
lanes 7-9). The heterodimer also bound cyclin A-kinase 
in vivo (Figure 48); however, T7-DP-l(AP) (lane 2), unlike 
T7-DP-l(wt) (lane l), was barely labeled when an anti-HA 
immunoprecipitate from cells cotransfected with HA-E2F- 
l(A5) (this pocket protein binding-defective mutant of 
E2F-1 was chosen for this experiment to avoid potential 
contamination of the anti-HA immunoprecipitate with any 
kinase that coprecipitates in a pocket-dependent fashion) 
and the mutant was exposed to an in vitro kinase reaction 
(compare lanes 2 and 1). The small amount of residual 
mutant DP-1 labeling was expected based on prior results 
(Krek et al., 1994) and likely reflects in vitro only labeling 
of non-SP sites (e.g., the intact C-terminal TP site) by 
E2F-l-bound cyclin A-kinase. By contrast, E2F-1 (A5) was 
labeled in both cases (Figure 48, lanes 1 and 2), in keeping 
with the prior observation that both E2F-1 and DP-1 are 
overtly phosphorylated in vitro when E2F-1 can bind cyclin 
A-kinase (Krek et al., 1994). Therefore, by multiple crite- 
ria, the mutant protein behaved similarly to wild-type pro- 
tein, with the exception of a marked decrease in in vitro 
phosphorylation, reflecting a defect in cyclin A-kinase la- 
beling. 
Recombinant retroviruses encoding T7-tagged versions 
of DP-l(AP) and wild-type DP-1 were used to infect NIH 
3T3 cells. Stably infected cultures were selected as pools 
of puromycin-resistant cells (uncloned mass cultures). 
These pools contained equivalent amounts of T-/-tagged 
DP-1 protein, as shown by Western blotting (Figure 4C, 
compare lanes 2 and 3). 
In multiple, independent experiments, these two pools 
were superinfected with equivalent amounts of wild-type 
E2F-l-encoding virus. In each case, shortly after infection, 
there was accumulation of S phase cells only in the mutant 
DP-l-containing culture (Figure 4D). The accumulation ef- 
fect was similar to that observed in the experiment shown 
in Figure 3A, in which linkage between binding of cyclin 
A-kinase to E2F-1 and normal passage through S phase 
was demonstrated. Therefore, S phase accumulation, the 
biological phenomenon most closely associated with non- 
binding of cyclin A-kinase to E2F-1, can also be linked to 
inability of E2F-l-bound kinase to phosphorylate DP-1. 
Characterization of E2F-l(A24) Double Mutants 
Specifically Defective in DNA Binding 
and Transactivation 
To test whether E2F-1 DNA binding or transactivation 
function (or both) contributes to the ability of the cyclin 
A-kinase binding-defective mutant E2F-l(A24) to induce 
S phase delay/arrest and subsequent apoptosis, retroviral 
expression plasmids encoding HA-tagged versions of the 
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Figure 4. Cotransfection of EPF-l(wt) and a Cyclin-Cdk Phosphoryla- 
tion Site Mutant of DP-1 Induces S Phase Arrest/Delay 
(A) Whole-cell lysates of U2-OS cells, either not transfected (lanes 
l-3) or cotransfected with expression plasmids encoding HA-E2F- 
l(wt) (10 ug) and T7-DP-l(wt) (10 ug) (lanes 4-6) or HA-EPF-l(wt) (10 
ug) and T7-DP-l(AP) (IO ug) (lanes 7-9) were subjected to immuno- 
precipitation with the anti-HA MAb 12CA5. lmmunoprecipitates were 
washed and treated with HA peptide (at a concentration of 2 mg/ml) 
to disrupt the antibody-antigen interaction, and supernatants were 
analyzed by EMSA for E2F DNA-binding activity in the absence (lanes 
1, 4, and 7) or presence of either anti-T7 MAb (lanes 2, 5, and 6) or 
control antibody PAb 419 (lanes 3, 6, and 9). Note the specific su- 
pershift effect in lanes 5 and 6, indicating that T7-tagged DP-l(wt) and 
T7-tagged DP-I(AP) had coimmunoprecipitated with HA-E2F-l(wt). 
(B) Whole-cell lysates of U2-OS cells, either not transfected (lane 3) 
or cotransfected with expression plasmids encoding HA-E2F-l(A5) (10 
ug) and T7-DP-l(wt) (10 ug) (lane 1) or HA-E2F-l(A5) (10 ug) and 
TFDP-l(AP) (10 pg) (lane 2) were subjected to immunoprecipitation 
with the anti-HA MAb 12CA5. lmmunoprecipitates were washed and 
subjected to an in vitro kinase reaction in the presence of [y-“PJATP. 
The migration positions of in vitro phosphorylated HA-EPF-l(A5) and 
coprecipitated T7-DP-l(wt) and T7-DP-l(AP) are denoted. Note that 
compared with T7-DP-l(wt) (lane l), T7-DP-l(AP) (lane 2) was poorly 
labeled under these conditions. 
(C) NIH 3T3 cells were infected with vector, T7-DP-I(wt), or T7-DP- 
l(AP) virus. After selection in puromycin, mass cultures (cell pools) 
of stably infected, puromycin-resistant cells were established. Lysates 
were prepared from each cell pool grown in parallel. These lysates 
were equalized for protein content and processed for Western blotting 
with anti-T7 MAb. Lane 1, vector-infected NIH 3T3 cells; lane 2, T7-DP- 
l(wt)-producing pool; lane 3, T7-DP-l(AP)-producing cell pool. Note 
that equivalent amounts of T7-tagged DP-1 proteins were present in 
the relevant cell pools. These pools were used in the experiments 
described in (D). 
(D) Puromycin-resistant cell pools, derived form NIH 3T3 cells infected 
in parallel with T7-DP-l(wt) or T7-DP-l(AP) (see [Cl), were superin- 
fected in separate experiments with either undiluted (left) or 1:4diluted 
(right) tissue culture supernatant containing retrovirus encoding HA- 
EPF-l(wt). At the indicated times postinfection, cultures were exam- 
ined for DNA content by propidium iodide staining and flow cytometry. 
The results shown represent relative changes (in percent) in the abun- 
dance of S phase cells in the indicated cultures at each datapoint 
compared with their abundance 12 hr after infection. The results of 
two independent experiments are shown here. 
following E2F-1 mutants were generated: a DNA binding- 
defective mutant (E2F-I(-DB); see Cress et al., 1993) and 
the double mutant derivative of it defective in cyclin 
A-kinase binding, E2F-l(A24/-DB); a transactivation- 
~$in A-Kinase-E2F-1 Interaction and Cell Cycle Control 
B HA-SWI C HA-E2P I 
Figure 5. Biochemical Characterization of Selected E2F-1 Mutants 
(A) Structure of E2F-l(wt) and selected mutant derivatives of it. The 
schematic depicts the cyclin A-kinase-binding domain of E2F-1 (cyc 
A-cdk), the DNA-binding domain (DED), and the transactivation do- 
main (TAD). From top to bottom, the following are shown: E2F-l(wt); 
E2F-l(A24); EZF-1 (-De); E2F-l(A24/-DB); E2F-I(-TA); E2F-l(A241 
-TA). See text for further explanations. 
(B) At 24 hpi, whole-cell lysates were prepared from NIH 3T3 cells 
infected either with vector (lane l), HA-E2F-l(wt) (lane 2). HA-E2F- 
l(A24) (lane 3) HA-EPF-I(-DB) (lane 4), HA-E2F-i(A24/-DE) (lane 
5) HA-EPF-1 (-TA) (lane 6) or HA-&F-l (A24/-TA) (lane 7) virus, and 
aliquots of each lysate were processed for Western blotting with the 
anti-HA MAb 12CA5. 
(C) Other aliquots from cell lysates prepared in (B) were processed for 
immunoprecipiation with the anti-HA MAb 12CA5. lmmunoprecipitates 
were washed and exposed to in vitro kinase reactions in the presence 
of 100 nglml histone HI. The bracket marks the position of in vitro 
phosphorylated histone HI. 
(D) Whole-cell extracts were prepared from NIH 3T3 cells at 24 hpi 
with either vector (lanes 1 and 2) HA-EPF-l(wt) (lanes 3 and 4) HA- 
E2F-l(A24) (lanes 5 and 6) HA-EPF-I(-DB) (lanes 7 and 8) HA-EPF- 
i(A24/-DB) (lanes 9 and IO), HA-EZF-I(-TA) (lanes 11 and 12) or 
HA-E2F-l(A24/-TA) virus (lanes 13 and 14) and analyzed by EMSA 
for E2F DNA-binding activity in the absence (lanes 1, 3, 5, 7, 9, 11, 
and 13) or presence (lanes 2, 4, 6. 8, 10, 12, and 14) of the anti-HA 
MAb 12CA5. 
defective mutant (E2F-I(-TA); see Flemington et al., 
1993) and the double mutant derivative of it, also defective 
in cyclin A-kinase binding, E2F-l(A24/-TA) (Figure 5A). 
Recombinant retroviruses encoding these HA-tagged 
E2F-1 proteins were generated and used to infect cultures 
of NIH 3T3 cells. All E2F-1 species under investigation 
were synthesized 24 hr after infection, as shown by West- 
ern blotting (Figure 58, lanes 2-7). Although there are 
variations in the abundances of the various E2F-1 species 
that were produced, we note that comparable quantities 
of each pair of E2F-1 proteins (the single mutant and the 
cognate A24 double mutant) were present (e.g., compare 
lanes 6 and 7). Thus, one can compare the behavior of 
a given E2F-1 species with its cyclin A-kinase binding- 
defective counterpart in a series of biological assays. 
As shown in Figure 5C, when anti-HA immunoprecipi- 
tates of NIH 3T3 cultures previously infected with the vari- 
ous E2F-l-encoding retroviruses were tested for associ- 
ated kinase activity, only the E2F-1 alleles with an intact 
cyclin A-binding domain, i.e., E2F-l(wt) (lane 2) E2F- 
1 (-DB) (lane 4) and E2F-1 (-TA) (lane 6), displayed his- 
tone Hl kinase activity. Thus, cyclin A-kinase binding to 
these various E2F-1 species was present where expected. 
The various E2F-1 species were also tested for DNA- 
binding activity. Whole-cell extracts were prepared in par- 
allel from NIH 3T3 cultures infected either with vector virus 
or with viruses encoding the various E2F-1 alleles and 
were tested in E2F gel shift assays (Figure 5D). To distin- 
guish between endogenous and exogenous E2F-l- 
containing gel shift complexes, each sample was treated 
in parallel with anti-HA antibody, in search of a specific 
supershift effect. Extracts from vector-infected cells con- 
tained two major bands (Figure 5D, lane 1). and as ex- 
pected, addition of anti-HA antibody failed to supershift 
either (lane 2). In E2F-l(wt)- and E2F-l(A24)-infected 
cells, an additional band was apparent (Figure 5D, lanes 3 
and 5) that supershifted upon addition of anti-HA antibody 
(lanes 4 and 6) indicating the presence of HA-EPF-l(wt) 
and HA-E2F-l(A24), respectively. As expected, in cells 
infected with those mutants that can no longer bind to 
DNA, E2F-l(-DB) and E2F-l(A24/-DB), no additional 
complexes were detected beyond those present in the 
vector-infected population (Figure 5D, lanes 7 and 9) and 
none were supershifted by anti-HA antibody (lanes 8 and 
10). By contrast, extracts of cells infected with E2F-1 mu- 
tants unable to transactivate, E2F-1 (-TA) and E2F-1 (A24/ 
-TA), each contained a major band (Figure 5D, lanes 11 
and 13), which was supershifted by the antibody (lanes 12 
and 14). Thus, as expected, deletion of the transactivation 
domain did not suppress E2F-1 DNA-binding activity. 
These results suggest that the relevant E2F-1 species are 
stably produced in vivo and behave as expected in various 
functional assays. 
E2F-l(A24)-Induced S Phase Delay/Arrest and 
Apoptosis Require Different Functional Domains 
Next, we analyzed the cell cycle behavior of NIH 3T3 cells 
infected in parallel with each of the mutant viruses de- 
scribed above. We also sought the appearance of sub- 
diploid cells as an indication of apoptosis. The cell cycle 
profiles (Figure 6A) and the fraction of cells that were sub- 
diploid (Figure 6B) in the infected cultures were recorded 
at the indicated times. Two major conclusions can be 
drawn from the results. First, S phase delay/arrest and 
apoptosis require, at aminimum, a functional DNA-binding 
domain, since cells infected by E2F-1 (A24/-DB), a mutant 
that is defective in both cyclin A-kinase binding and DNA 
binding, did not alter the cell cycle profile of NIH 3T3 cells 
(Figure 6A, bars marked A24/-DB), nor did it induce 
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Figure 6. Genetic Analysis of EZF-1 Functions Essential for S Phase 
Progression and Suppression of Apoptosis 
(A) NIH 3T3 cells were infected with either vector, HA-E2F-l(wt), HA- 
E2F-l(A24), HA-EOF-l(-DB), HA-E2F-l(A24/-DB), HA-EPF-l(-TA), 
or HA-E2F-l(A24/-TA) virus and examined for DNA content by FACS 
analysis at 24 hpi (top) and 48 hpi (bottom). These data are typical of 
several independent experiments. 
(6) Percentages of cells displaying a DNA content less than that of 
Gl cells in the analysis portrayed in (A) at 48 hpi. These cells were 
labeled apoptotic cells. 
apoptosis (Figure 6B, bar marked A24/-DB). Second, the 
transactivation domain is dispensable for efficient S phase 
delay/arrest, but is required for apoptosis. At 24 hpi, a 
culture producing E2F-l(A24/-TA), a mutant defective in 
cyclin A binding and in transactivation, revealed a dra- 
matic increase in S phase cells (Figure 6A, top, bars 
marked A24/-TA). E2F-1 (A24)-infected cells, analyzed in 
parallel, revealed a similar profile (Figure 6A, top, bars 
marked A24). At 48 hpi, the majority of the E2F-i(A24/ 
-TA)-infected cells were still in S phase (Figure 6A, bot- 
tom, bars marked A24/-TA), but did not die (Figure 66, 
bar marked A24/-TA). In keeping with prior results (see 
Figure 38), a significant fraction of E2F-l(A24)-producing 
cells were subdiploid at that time and were, therefore, 
apoptotic (Figure 6B, bar marked A24). 
Importantly, no cell cycle effects were observed in cul- 
tures producing a species of E2F-1, E2F-I(-TA), that is 
defective in transactivation and pocket protein binding, 
but is otherwise intact (Figure 6A, bars marked -TA). This 
species bound cyclin A-kinase (see Figure 5C). Thus, one 
might argue that S phase delay/arrest is mediated by the 
unscheduled binding of E2F-1 to specific DNA sequences 
that results, at least in part, from failure of cyclin A-kinase 
to bind to E2F-1 and to phosphorylate DP-1. The latter 
translates into an inability to eliminate the DNA binding 
function of the heterodimer in S (Krek et al., 1994). In 
keeping with this explanation, cells synthesizing compara- 
ble quantities of a mutant unable to bind both cyclin A and 
DNA (A24/-DB) failed to delay/arrest in S phase and to 
die (Figure 6). Therefore, the apoptotic response requires 
both unscheduled, specific E2F-1 DNA-binding activity 
and the presence of an E2F-1 transactivation domain. 
Altered Growth Control in ESF-l(-TA)- and 
E2F-i(A24/-TA)-Producing Cells 
To test whether E2F-l(A24/-TA)-induced S phase arrest 
was transient or irreversible, NIH 3T3 cells were infected 
with retroviruses encoding various HA-tagged E2F-1 al- 
leles. Stably infected cultures were selected as pools of 
puromycin-resistant cells (uncloned mass cultures). Drug 
selection was initiated 48 hpi. 
Virtually all cells of either vector- or EPF-l(-DB)-, E2F- 
1 (A24/-DB)-, E2F-1 (-TA)-, and E2F-1 (A24/-TA)-infected 
cultures were puromycin resistant and could be readily 
expanded into mass cultures (cell pools). The majority of 
cells from wild-type E2F-l-infected cultures were also re- 
sistant to puromycin, although 150/o-20% of them died 
within the first 4 days. By contrast, as expected, only a 
fewcellsof E2F-l(A24)-infected NIH3T3culturessurvived 
the puromycin selection. 
The production of the relevant E2F-1 proteins in these 
various mutant and wild-type virus-infected cell pools was 
assessed by Western blotting with an anti-HA antibody. As 
shown in Figure 7A, the HA-tagged E2F-1 mutant proteins, 
i.e., E2F-I(-DB), E2F-l(A24/-DB), E2F-I(-TA), and E2F- 
l(A24/-TA), were readily detected as distinctive bands 
of roughly equivalent intensity at the expected positions 
(lanes 4-7, respectively). Thus, E2F-l(A24/-TA)-induced 
S phase arrest was transient, and cells synthesizing the 
double mutant protein eventually resumed replication. 
E2F-l(wt)-infected pools contained significantly less 
E2F-1 protein than pools infected with the respective DNA- 
binding or transactivation-defective mutants. No HA- 
reactive bands were detected in pools established from 
vector-infected cells (Figure 7A, lane 1). Finally, in 
agreement with the fact that production of E2F-1 (A24) pro- 
voked wide spread apoptosis, E2F-l(A24) bands were ab- 
sent from the established pool(s) of survivors that were 
tested (Figure 7A, lane 3). 
Since some of these cultures had broken through at 
least one level of S phase control, they were tested for 
other evidence of growth deregulation. Surprisingly, both 
the E2F-l(A24/-TA) pool and the culture synthesizing 
E2F-I(-TA), evaluated as a control, grew in agar (Figures 
7Bf and 7Be, respectively) and formed tumors in nude 
mice (Figure 7C). Notably, the former grew more efficiently 
in both assays (compare Figures 7Bf and 7Be as well as 
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Mutants of E2F-1 Defective in Cyclin A-Kinase 
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2.0 (A) NIH 3T3 cells were infected with the retrovi- 
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ruses indicated in Figure 5A and, after selec- 
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0.4 3 processed for Western blotting with the anti-HA 
MAb 12CA5. Lane 1, vector-infected NIH 3T3 
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cells; lane 2, HA-EZF-l(wt)-producing pool; 
lane 3, pool of HA-EPF-1 (A24)-infected cells; 
lane 4, HA-E2F-1(-DB)-producing pool; lane 5, 
HA-EPF-l(A24/-DB)-producing pool; lane 6, 
HA-EPF-I(-TApproducing pool; lane 7, HA- 
E2F-l(A24/-TA)-producing pool. At least three 
such pools were established and analyzed for 
each recombinant virus with similar results. 
(B) Stably infected, puromycin-resistant cell 
pools, derived from NIH 3T3 cells infected with vector control virus (a) or with virus encoding HA-EPF-l(wt) (b), HA-E2F-I(-DB) (c), HA-EPF-l(A241 
-DE) (d), HA-EPF-1 (-TA) (e), or HA-E2F-1 (A24/-TA) (9 were assayed for their ability to grow in soft agar. Cells were photographed after 14 days 
in culture. The results obtained with one of three equivalent pools of cells infected by each E2F-1 recombinant virus (as indicated in Figure 5A) 
are shown here. 
(C) Cells (I x 106) of each pool stably producing either HA-EZF-I(-TA) or HA-E2F.l(A24/-TA) were independently injected into nude mice (four 
mice per dilution). After 7 weeks (right panel), palpable tumors were measured with a caliper to estimate tumor volume. The vertical lines indicate 
standard deviations. The numbers on top of each bar represent numbers of mice (out of the four injected for each dilution) with detectable tumors 
at 7 weeks (riqht) postinjection. Injection of mice with vector-infected control cells was performed in parallel and resulted in the growth of one very 
small tumor in the 16 mice analyied. 
the left and right solid bars in Figure 7C), although equiva- 
lent quantities of these two proteins were present in the 
cells that were analyzed (Figure 7A). 
NIH 3T3 cells infected with wild-type E2F-1 virus also 
grew in agar (Figure 7Bb), as reported earlier (Xu et al., 
1995). As expected, neither naive NIH 3T3 (Figure 7Ba), 
nor pools containing E2F-1 species lacking DNA binding 
function (Figures 7Bc and 7Bd) scored positively in these 
tests. These data suggest that an E2F-1 species that 
is intact, except for its ability to both transactivate and 
bind to RB, is an oncogene. In addition, failure of cyclin 
A-kinase to bind to E2F-1 appears to heighten, signifi- 
cantly, the oncogenic action of this truncated protein. 
Discussion 
The results reported here indicate that cyclin A-kinase 
regulation of E2F-1, a transcription factor equipped with 
a dedicated cyclin A-kinase-binding domain, promotes 
uninterrupted S phase passage and cell survival. It ap- 
pears that phosphorylation of the E2F-1 heterodimeric 
partner, DP-1, on a specific cyclin-cdk phosphoacceptor 
site(s) by E2F-l-bound cyclin A-kinase is linked to the 
suppression of E2F-l-dependent S phase arrest/delay. 
Thus, we propose that E2F-1, the DNA binding function 
of which is normally down-regulated in S phase by bound 
cyclin A-kinase (Krek et al., 1994) participates in the acti- 
vation of a specific cell cycle checkpoint when regulation 
by cyclin A-kinase fails. Activation of this checkpoint was 
only observed when the cyclin A-less transcription factor 
could still perform its sequence-specific DNA binding func- 
tion. Thus, one might argue that, for normal cell cycling, 
the presence of E2F-1 on cognate DNA sequences must 
be confined to a specific time interval in the cell cycle. 
Given these observations, it is tempting to speculate that 
there is a cellular monitoring system that is, in part, capa- 
ble of sensing DNA-bound E2F-1 (or certain of its mutant 
derivatives) and that when it does so after a certain point 
in S, a checkpoint is activated. 
Since E2F-1 (A24/-TA) and E2F-l(A24) both induced S 
phase arrest/delay, but only the latter induced arrest/delay 
and death, it would appear that these two biological out- 
comes are, in part, dissociable. The delay/arrest pheno- 
type is apparently a product of E2F-1 functions short of 
full, sequence-specific transcription activation. Included 
among them is specific DNA binding. By contrast, for cell 
killing, full E2F-1 function appeared to be necessary, as 
if continuous E2F-1 stimulation of certain promoters after 
S phase arrest/delay contributed significantly to the ensu- 
ing apoptosis. 
In normal cells, E2F-1 is bound to DNA during part of 
Gl and early S, and this timing contributes to its normal 
function. For example, E2F-1 species that are defective 
in DNAbindingcannotdriveaGOcellintoS(Johnsonetal., 
1993; Shan and Lee, 1994). In light of the results reported 
here, one might further suggest that unscheduled E2F-1 
DNA-binding activity during S phase interferes with the 
ongoing DNA replication process. For example, the bind- 
ing of E2F-1 to certain promoters during S phase might, in 
theory, prevent the normal passage of selected replication 
forks. One outcome of such a circumstance might be stall- 
ing of the relevant replication complexes and delayed pro- 
gression of cells through S phase. In this regard, an origin 
of replication has been mapped downstream of the DHFR 
gene (Burhans et al., 1990). Moreover, a functional E2F- 
binding site exists in the promoter of that gene (Blake and 
Azizkhan, 1989). E2F binding to that site contributes to 
the late-G1 activation of this promoter (Means et al., 1992). 
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Conceivably, prolonged binding of E2F to that site perturbs 
the procession of replication forks emerging from the 
nearby origin. Clearly, other possibilities exist. However, 
existing evidence suggests a relationship between replica- 
tion timing and the transcription of certain genes (for re- 
cent review see Coverley and Laskey, 1994). Thus, cou- 
pling the timing of transcription of at least some genes to 
the control of replication may be critical for normal cell 
cycle progression. 
The failure of cyclin A-kinase to bind to E2F-1 was asso- 
ciated with the accumulation of S phase cells. This, most 
likely, reflects the development of S phase arrest/delay 
as opposed to selective death of Gl cells. First, after intro- 
ducing the relevant E2F-1 mutants, there was overt accu- 
mulation of S phase cells (at 24 hr) before the appearance 
of apoptotic cells, as measured by any of the assays em- 
ployed. Second, by 48 hr after infection with E2F-l(A24) 
virus, most of the cells were in the process of dying, and 
the majority of the cell population at the time were S phase 
cells. Third, at 48 hr after infection, there was a relative 
enrichment of Gl cells in the E2F-l(A24)-infected culture 
(see Figure 3A). 
It also seems unlikely that the observed accumulation 
of S phase cells resulted from E2F-1 stimulation of Gl 
exit. In support of this, E2F-l(A24) and E2F-l(A24/-TA) 
induced roughly equivalent degrees of S phase cell accu- 
mulation, yet without its transactivation domain, E2F-1 
was unable to drive Gl cells into S phase (Johnson et al., 
1993; Shan and Lee, 1994). 
The E2F-l-dependent death observed during the exper- 
iments described here does not appear to be a result of 
the mechanism underlying previously documented, E2F-l- 
dependent apoptosis in growth factor-deprived cells 
(Shan and Lee 1994; Qin et al., 1994; Wu and Levine, 
1994; Kowalik et al., 1995). In all of the experiments re- 
ported here, cells were cultivated in high serum-containing 
medium, which was shown to suppress E2F-l-dependent 
death in growth factor-deprived cells. 
That NIH 3T3 cells producing DP-l(AP) were not growth 
arrested per se requires comment. In prior experiments, 
it was shown that the endogenous levels of DP-1 in various 
cells are high and that there was much more DP-1 than 
E2F-1 in those cells that have been tested (Girling et al., 
1993). Moreover, it was shown that overproduction of 
E2F-1 recruits endogenous DP-1 into functional hetero- 
dimeric complexes. In contrast, a minimal or no effect was 
seen when DP-1 was overproduced (Krek et al., 1993; 
Helin et al., 1993; Bandara et al., 1993). Hence, one can 
speculate that, even in cells producing ectopic DP-l(AP), 
a phenotype resulting from the phosphosite mutations 
may not come to light until the E2F level is increased, e.g., 
by E2F-1 recombinant retroviral infection. 
As expected, wild-type E2F-l-infected cells displayed 
transformed characteristics. Indeed, E2F-1 has been 
shown to transform fibroblast cell lines, to render them 
tumorigenic, and to be down-modulated as an oncoprotein 
by pRB binding (Singh et al., 1994; Johnson et al., 1994; 
Xu et al., 1995). Yet, two observations were surprising. 
First, cells infected by a retrovirus encoding an E2F mutant 
lacking a transactivating domain, E2F-l(-TA), grew in 
agar and formed tumors in nude mice. On the other hand, 
an otherwise intact E2F species unable to bind to DNA 
was inactive in this regard. Thus, one could argue that 
E2F-I(-TA) transforms, in part, through its DNA binding 
function. One explanation of how this might occur is based 
upon recent evidence that RB-E2F-1 complexes bind to 
certain E2F site-containing promoters and repress their 
function, thereby resulting in Gl arrest (Bremner et al., 
1995; Weintraub et al., 1995; Sellers et al., 1995). That 
being the case, it is possible that E2F-I(-TA), which heter- 
odimerizes with DP, binds to E2F sites (Figure 5D) and, 
lacking pRB binding function, competes with RB-EPF 
complexes for binding to DNA. This might, in turn, relieve 
repression of certain promoters and overcome the prolifer- 
ation block. 
The second unexpected observation was that cells syn- 
thesizing E2F-I(-TA) displayed a less potent transformed 
phenotype than cells producing comparable amounts of 
E2F-1 (A24/-TA). This suggests that cyclin A-kinase bind- 
ing to E2F-1 suppresses its transforming function. Whether 
this depends upon DP-1 serine phosphorylation, like pro- 
gression through S phase, is unknown. However, this ef- 
fect might be related to the expected noncompetition with 
S phase-specific, pocket protein-E2Fcomplexesfor bind- 
ing to chromosomal E2F sites by free E2F-l-DP hetero- 
dimers, rendered unable to bind DNA by cyclin A-kinase 
phosphorylation. Indeed, both, RB- and pl07-containing 
E2Fcomplexes exist through much of S phase (Shirodkar 
et al., 1992; Cao et al., 1992; Devoto et al., 1992), when 
cyclin A-kinase-E2F-1 complexes are maximally appar- 
ent (Krek et al., 1994). 
Whatever the details of the mechanism, assuming that 
free E2F-DP complexes promote cell growth and pocket 
protein-E2F complexes contribute to growth control, it 
seems reasonable to link cyclin A-kinase-E2F-1 binding 
to the suppression of E2F-1 transforming action. This con- 
clusion notwithstanding, direct analysis of how cyclin 
A-kinase binding to E2F-1 suppresses its transforming 
potential is needed. 
Although knowledge of the biochemical events connect- 
ing cyclin A-kinase-E2F-1 binding and proper S phase 
control is incomplete, the data presented here suggest 
that cyclin A-kinase-E2F complex formation represents 
a possible target for the development of antitumor thera- 
peutic strategies that depend upon the specific action of 
certain small-molecule compounds. In principle, com- 
pounds that interfere selectively with the cyclin A-kinase- 
E2F-1 interaction may well lead to death of certain replicat- 
ing cell types. 
Experimental Procedures 
Construction of Plasmids 
The construction of a retroviral expression plasmid encoding HA- 
tagged wild-type E2F-1, pBabe(puro)HA-E2F-l(wt), has been de- 
scribed previously (Xu et al., 1995). cDNAs encoding HA-tagged ver- 
sions of E2F-l(A24) and E2F-l(A7) (Krek et al., 1994) were cloned 
into the retroviral expression plasmid pBabe(puro) (Morgenstern and 
Land, 1990). The plasmids pCMV-E2F-l(E177) (Cress et al., 1993) 
y;$n A-Kinase-E2F-1 Interaction and Cell Cycle Control 
and GAL4-RBAP-l(l-368) (Flemington et al., 1993) were converted 
to pBabe(puro)HA-E2F-I(-DB) and pBabe(puro)HA-E2F-1(-TA). The 
corresponding double mutant derivates pBabe(puro)HA-E2F-l(A24/ 
-DB) and pBabe(puro)HA-E2F-l(A24/-TA) were created from the re- 
sulting plasmids. cDNAs encoding T7-tagged versions of wild-type 
DP-1 and a mutant derivative of it, DP-l(AP), lacking all potential 
N-terminal cyclin-cdk phosphoacceptor sites (generated by polymer- 
ase chain reaction [PCR] mutagenesis using appropriate mutant oligo- 
nucleotides as primers) were also cloned into pBabe(puro). Details of 
plasmid construction are available upon request. 
Cell Culture, DNA Transfection, and Retroviral Infection 
U2-OS and NIH 3T3 cells were cultivated as described previously (Krek 
et al., 1994). The retroviral packaging cell line BOSC23 (Pear et al., 
1993) was maintained in DMEM containing 10% fetal calf serum at 
37°C in a 10% CO? atmosphere. 
Transfection of U2-OS cells was performed as described (Krek et 
al., 1993). BOSC23 cells were transfected with a total of 30 Kg Of 
pBabe(puro) plasmid DNA or its derivatives (containing the indicated 
HA-tagged E2F-1 alleles) by calcium phosphate coprecipitation, as 
described (Pear et al., 1993). Medium containing the retrovirus was 
harvested 24-30 hr following removal of the precipitate and used to 
infect NIH 3T3 cells at 30% confluency (see Xu et al., 1995). Uncloned 
pools of puromycin-resistant NIH 3T3 were generated as described 
(Xu et al., 1995). 
Antibodies, In Vitro Kinase Assays, Gel Mobility Shifi Assays, 
and Western Blotting 
The affinity-purified mouse monoclonal antibody (MAb) 12CA5, which 
recognizes a specific influenza viral HA epitope, was purchased from 
BAbCo. The mouse Mab recognizing the T7 tag was obtained from 
Novagen. In vitro kinase reactions and gel mobility shift assays were 
carriedout asdescribed by Krekand Nigg(1991) and Kreket al. (1993), 
respectively. For immunoblotting experiments, whole-cell extracts 
were prepared (Krek et al., 1993), and cellular proteins were resolved 
by SDS-PAGE. Antibody detection was achieved by ECL-enhanced 
chemiluminescence (Amersham), according to the protocol of the man- 
ufacturer. 
Cell Cycle Analysis and Apoptosis Assays 
For cell cycle analysis, NIH 3T3 cells were harvested by trypsinization 
at the indicated times postinfection and processed for FACS analysis, 
as described (Krek and Nigg, 1991). Flow cytometric quantitation Of 
apoptotic cells within the propidium iodide-stained population was 
also performed as described (Nicoletti et al., 1991). 
Chromatin morphology was visualized by staining paraformalde- 
hyde-fixed cells of virus-infected cultures with DAPI at48 hpi. Fragmen- 
tation of cellular DNA was measured 48 hr after infection of NIH 3T3 
cells with various retroviruses, as described (Lowe et al., 1993). 
Soft Agar Assays and Tumor Formation in Nude Mice 
Soft agar assays were performed as described (Xu et al., 1995). TO 
assay tumor formation in nude mice, uncloned pools of puromycin- 
resistant NIH 3T3 cells producing the various E2F-1 alleles were tryp- 
sinized, counted, and resuspended in PBS. Cells in a total volume of 
100 ~1 were then injected into 2-to 3-week-old nude mice. Mice were 
scored for the presence of tumors at the injection sites at weekly inter- 
vals. The length (I) and width (w) of tumors was measured with a mi- 
crometer, and the approximate ellipsoid tumor volume (tv) was calcu- 
lated using the equation (I) x (w) x 0.562 = (tv). 
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